Takip et
Salih Aksu
Salih Aksu
Hacettepe Üniversitesi Tıp fakültesi
hacettepe.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Hemostatic efficacy of Ankaferd Blood Stopper® in a swine bleeding model
H Bilgili, A Kosar, M Kurt, IK Onal, H Goker, O Captug, A Shorbagi, ...
Medical Principles and Practice 18 (3), 165-169, 2009
1272009
Endoscopic application of ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: a case report
M Kurt, S Disibeyaz, M Akdogan, N Sasmaz, S Aksu, IC Haznedaroglu
Official journal of the American College of Gastroenterology| ACG 103 (8 …, 2008
1272008
Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis
M Kurt, M Akdogan, IK Onal, M Kekilli, M Arhan, A Shorbagi, S Aksu, ...
Digestive and Liver Disease 42 (3), 196-199, 2010
1072010
In vitro anti-bacterial activities of Ankaferd medicinal plant extract
N Akkoc, M Akcelik, IC Haznedaroglu, H Goker, M Turgut, S Aksu, ...
Turkiye Klinikleri Tip Bilimleri Dergisi 29 (2), 410-415, 2009
772009
Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia.
Y Beyazit, S Aksu, IC Haznedaroglu, M Kekilli, M Misirlioglu, S Tuncer, ...
Journal of the National Medical Association 99 (1), 57, 2007
622007
In vitro anti-bacterial activities of Ankaferd blood stopper
N Akkoc, M Akceik, I Haznedaroglu, H Goker, S Aksu, S Kirazli, H Firat
International Journal of Laboratory Hematology 30, 2008
552008
EUTOS CML prognostic scoring system predicts ELN-based ‘event-free survival’better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
B Uz, Y Buyukasik, H Atay, E Kelkitli, M Turgut, O Bektas, E Eliacik, A Isik, ...
Hematology 18 (5), 247-252, 2013
482013
Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML
S Aksu, Y Beyazit, IC Haznedaroglu, H Canpinar, M Kekilli, A Uner, ...
Leukemia & lymphoma 47 (5), 891-896, 2006
472006
Discovering blood donor arrival patterns using data mining: A method to investigate service quality at blood centers
MC Testik, BY Ozkaya, S Aksu, OI Ozcebe
Journal of medical systems 36, 579-594, 2012
462012
Determination of burnout levels of nurses working in stem cell transplantation units in Turkey
Y Akkuş, Y Karacan, H Göker, S Aksu
Nursing & health sciences 12 (4), 444-449, 2010
412010
Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy
S Serefhanoglu, Y Buyukasik, H Goker, N Sayinalp, IC Haznedaroglu, ...
Leukemia Research 34 (12), e317-e319, 2010
332010
Spontaneous tumor lysis syndrome in a patient with diffuse large B cell lymphoma and Richter syndrome
A Tufan, N Unal, E Koca, I Onal, S Aksu, I Haznedaroglu
Annals of Hematology 85, 183-184, 2006
312006
Anti-cancer activity of Ankaferd on human colon cancer (CACO-2) in vitro
H Goker, E Kilic, D Cetinkaya, Y Buyukasik, S Aksu, M Turgut, ...
Ankaferd: Scientific perspectives and basic-clinical data. Istanbul, Naviga …, 2008
302008
Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia
S Serefhanoglu, Y Buyukasik, H Emmungil, N Sayinalp, IC Haznedaroglu, ...
International Journal of Medical Sciences 8 (1), 30, 2011
292011
Spinal myeloid sarcoma in two non-leukemic patients
S Serefhanoglu, H Goker, S Aksu, Y Buyukasik, N Sayinalp, ...
Internal Medicine 49 (22), 2493-2497, 2010
292010
Local umbilical cord blood renin–angiotensin system
H Goker, IC Haznedaroglu, Y Beyazit, S Aksu, S Tuncer, M Misirlioglu, ...
Annals of hematology 84, 277-281, 2005
292005
Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
S Turk, UY Malkan, M Ghasemi, H Hocaoglu, D Mutlu, G Gunes, S Aksu, ...
SAGE open medicine 5, 2050312116689519, 2017
282017
The value of early treatment in patients with haemophilia and inhibitors
K Kavakli, A Yesilipek, B Antmen, S Aksu, C Balkan, D Yilmaz, A Kupesiz, ...
Haemophilia 16 (3), 487-494, 2010
282010
The value of early treatment in patients with haemophilia and inhibitors
K Kavakli, A Yesilipek, B Antmen, S Aksu, C Balkan, D Yilmaz, A Kupesiz, ...
Haemophilia 16 (3), 487-494, 2010
282010
Hyper-CVAD regimen in routine management of adult acute lymphoblastic leukemia: a retrospective multicenter study
Y Buyukasik, K Acar, E Kelkitli, B Uz, S Serefhanoglu, E Ozdemir, ...
Acta haematologica 130 (3), 199-205, 2013
262013
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20